Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5
Closed -$15.3K 879
2023
Q3
$15.3K Hold
5
﹤0.01% 818
2023
Q2
$19.8K Hold
5
﹤0.01% 813
2023
Q1
$24K Hold
5
﹤0.01% 829
2022
Q4
$16.5K Hold
5
﹤0.01% 825
2022
Q3
$26K Hold
5
﹤0.01% 801
2022
Q2
$18K Hold
5
﹤0.01% 787
2022
Q1
$25K Hold
5
﹤0.01% 846
2021
Q4
$60K Hold
5
﹤0.01% 837
2021
Q3
$65K Buy
+5
New +$58.9K ﹤0.01% 812

Other funds holding NCNA

Moors & Cabot's NCNA Position: Q4 2023 in Review

Moors & Cabot sold out of NuCana (NCNA) in Q4 2023, closing a stake of 5 shares — an estimated $15.3K sold.

Moors & Cabot first reported a position in NCNA in Q3 2021 and held it in 9 quarters. The position peaked at $65K in Q3 2021. 18 funds tracked by Wall St. Rank hold NCNA as of Q4 2023.

  • Moors & Cabot reported no remaining NuCana position as of Q4 2023 after selling out during the quarter.
  • Moors & Cabot sold 5 NuCana shares in Q4 2023, an estimated $15.3K.
  • Moors & Cabot first reported a position in NuCana in Q3 2021 and held it in 9 quarters.
  • Moors & Cabot's NuCana position peaked at $65K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held NuCana as of Q4 2023.

Based on Moors & Cabot's 13F filing for Q4 2023, filed 14 Feb 2024.